Authors
No takes yet. Share an insight, caveat, or question.
Narrative review reveals Nampt-driven NAD modulation controls inflammatory and survival pathways in cells, highlighting its promise as a dual antitumor and anti-inflammatory drug target.
Gallí et al. (2009) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: